<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04751110</url>
  </required_header>
  <id_info>
    <org_study_id>98/05</org_study_id>
    <nct_id>NCT04751110</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Rhomboid Intercostal Block for Myofascial Pain Syndrome</brief_title>
  <official_title>Ultrasound Guided Rhomboid Intercostal Block for Myofascial Pain Syndrome: Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Teaching and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Teaching and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rhomboid intercostal block (RIB) is an interfacial plane block described in 2016. It creates&#xD;
      analgesia at T2-T9 levels in the hemithorax by applying local anesthetic to the fascia&#xD;
      between the rhomboid muscle and the intercostal muscle. It has been used effectively in&#xD;
      patients with chronic pain. Recently published report has shown that rhomboid intercostal&#xD;
      block (RIB) may provide effective pain control for myofascial pain syndrome (MPS), too. MPS&#xD;
      is a regional pain syndrome characterized by trigger points detected in one or more regional&#xD;
      muscle groups. The investigators planned a prospective observational study, a total of 30&#xD;
      patients who will apply to our clinic with MPS, will register in research. The investigators&#xD;
      will perform ultrasound-guided RIB, and evaluate the clinical outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myofascial pain syndrome (MPS) is the most common cause of musculoskeletal pain and its&#xD;
      prevalence in the population is reported to be 21-30%. Rhomboid intercostal block (RIB) is an&#xD;
      interfacial plane block described in 2016. It creates analgesia at T2-T9 levels in the&#xD;
      hemithorax by applying local anesthetic to the fascia between the rhomboid muscle and the&#xD;
      intercostal muscle. It has been used effectively in patients with chronic pain. The&#xD;
      investigators planned a prospective observational study.From february to march 10 2021, a&#xD;
      total of 30 patients who will apply to our clinic with MPS, will register in research. The&#xD;
      investigators will perform ultrasound-guided RIB, and evaluate the clinical outcome&#xD;
      Ultrasound guided RIB will applied with linear probe, in plane technique. Block needle was&#xD;
      inserted to plane between the rhomboid muscle and intercostal muscles over the T5-6 ribs 2 cm&#xD;
      to 3 cm medially from the medial border of the scapula. 13ml of bupivacaine 0.25% and 8mg&#xD;
      dexamethasone mixture will inject into the fascial plane. Numerical Rating Scale (NRS) will&#xD;
      recorded before and after the block at 30 minutes, day 1, 1-2-4-6 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 10, 2021</start_date>
  <completion_date type="Actual">April 26, 2021</completion_date>
  <primary_completion_date type="Actual">March 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical Rating Scale (NRS) Pain Score Change</measure>
    <time_frame>Change from baseline to minutes 30, day 1, week 1, 2, 4, 6 after the block</time_frame>
    <description>The 11-point NRS consists of numbers between 0 and 10 where 0 indicates &quot;no pain&quot; and 10 indicates &quot;maximum pain.&quot; The patient is instructed to identify one number between 0 and 10, which is best representative of their pain intensity.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Myofascial Pain Syndrome</condition>
  <arm_group>
    <arm_group_label>block group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>ultrasound guided rhomboid intercostal block will performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ultrasound guided rhomboid intercostal block</intervention_name>
    <description>A linear ultrasound probe was medially placed in the sagittal plane on the medial border of the scapula at the T5-T7 level. We inserted a 22-gauge needle into the fascial plane between the rhomboid major and intercostal muscles in a craniocaudal direction and injected 15 ml mixture of 0.25% bupivacaine with 8 mg of dexamethasone into the fascial plane.</description>
    <arm_group_label>block group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Complaint of myofascial pain&#xD;
&#xD;
          -  Pain that is rated at least 3 on a numerical rating scale (NRS, 0 = no pain, 10 = the&#xD;
             worst pain)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  the presence of coagulopathy, or the use of anticoagulants&#xD;
&#xD;
          -  a history of surgery on the block area&#xD;
&#xD;
          -  allergic to bupivacaine&#xD;
&#xD;
          -  decline to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Selin Guven Kose</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diskapi Yildirim Beyazit Education and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diskapi Yildirim Beyazit Training and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06110</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Borg-Stein J, Iaccarino MA. Myofascial pain syndrome treatments. Phys Med Rehabil Clin N Am. 2014 May;25(2):357-74. doi: 10.1016/j.pmr.2014.01.012. Epub 2014 Mar 17. Review.</citation>
    <PMID>24787338</PMID>
  </reference>
  <reference>
    <citation>Ekinci M, Ciftci B, Alici HA, Ahiskalioglu A. Ultrasound-guided rhomboid intercostal block effectively manages myofascial pain. Korean J Anesthesiol. 2020 Dec;73(6):564-565. doi: 10.4097/kja.20211. Epub 2020 May 12.</citation>
    <PMID>32392670</PMID>
  </reference>
  <reference>
    <citation>Piraccini E, De Lorenzo E, Maitan S. Rhomboid intercostal block for myofascial pain syndrome in a patient with amyotrophic lateral sclerosis. Minerva Anestesiol. 2019 Dec;85(12):1367-1369. doi: 10.23736/S0375-9393.19.13791-1. Epub 2019 Jul 22.</citation>
    <PMID>31334619</PMID>
  </reference>
  <reference>
    <citation>Elsharkawy H, Saifullah T, Kolli S, Drake R. Rhomboid intercostal block. Anaesthesia. 2016 Jul;71(7):856-7. doi: 10.1111/anae.13498.</citation>
    <PMID>27291611</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>February 5, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>November 7, 2021</last_update_submitted>
  <last_update_submitted_qc>November 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Teaching and Research Hospital</investigator_affiliation>
    <investigator_full_name>Selin Guven Kose</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>rhomboid intercostal block</keyword>
  <keyword>ultrasound guided block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

